Modulation by serotonin of glutamate-induced lethality in mice
- PMID: 1839809
Modulation by serotonin of glutamate-induced lethality in mice
Abstract
To determine the involvement of serotonergic mechanisms in glutamate-induced excitotoxicity, the effects on glutamate-induced lethality of drugs that modify serotonergic transmission were studied in mice. Monosodium glutamate (MSG; 6-10 g/kg, i.p.) produced a dose-related increase in lethality in mice. Pretreatment with reserpine (2.5 mg/kg, i.p., 5 hr) resulted in an increase in MSG-induced lethality. p-Chlorophenylalanine (PCPA; 300 mg/kg, i.p. 24 hr) specifically produced a reduction of more than 60% in the level of 5-HT in the brain. PCPA-treated mice were also more sensitive to the lethal effects of MSG. alpha-Methyl-p-tyrosine (300 mg/kg, i.p. 5 hr) produced a significant reduction in the levels of norepinephrine and dopamine in the brain, but the sensitivity to the lethal effects of MSG was unchanged. L-Tryptophan (300 and 500 mg/kg, i.p.) and 5-hydroxy-L-tryptophan (5-HTP; 3-30 mg/kg, i.p.), precursors of serotonin (5-HT), protected mice to a significant extent against MSG-induced lethality, in a dose-related manner. 1-(m-Trifluoromethylphenyl) piperazine (TFMPP; 50 mg/kg, i.p.), an agonist of 5-HT1 receptor, was also associated with protection against MSG-induced lethality. This protective effect was not observed in PCPA- or methysergide-treated mice. These results suggested that 5-HT in the brain may play an inhibitory role in MSG-induced excitotoxicity.
Similar articles
-
Involvement of serotonergic mechanisms in the inhibitory effect of U-50,488H on glutamate-induced lethality in mice.Res Commun Chem Pathol Pharmacol. 1992 Mar;75(3):357-60. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1509202
-
Monoamines and the mechanisms of action of antitussive drugs in rats.Arch Int Pharmacodyn Ther. 1987 Nov;290(1):117-27. Arch Int Pharmacodyn Ther. 1987. PMID: 2965557
-
Central action of narcotic analgesics. VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats.Pol J Pharmacol Pharm. 1981 Mar-Apr;33(2):193-202. Pol J Pharmacol Pharm. 1981. PMID: 6458804
-
The brain serotonergic system in the affective disorders.Prog Neuropsychopharmacol. 1978;2(1):5-31. doi: 10.1016/0364-7722(78)90019-x. Prog Neuropsychopharmacol. 1978. PMID: 214806 Review. No abstract available.
-
Excitotoxicity triggered by neonatal monosodium glutamate treatment and blood-brain barrier function.Arch Med Res. 2014 Nov;45(8):653-9. doi: 10.1016/j.arcmed.2014.11.014. Epub 2014 Nov 26. Arch Med Res. 2014. PMID: 25431840 Review.
Cited by
-
Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.Parkinsonism Relat Disord. 2021 Feb;83:56-62. doi: 10.1016/j.parkreldis.2021.01.010. Epub 2021 Jan 13. Parkinsonism Relat Disord. 2021. PMID: 33476879 Free PMC article.
-
5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.Bioorg Med Chem Lett. 2014 Mar 15;24(6):1489-92. doi: 10.1016/j.bmcl.2014.02.029. Epub 2014 Feb 19. Bioorg Med Chem Lett. 2014. PMID: 24582985 Free PMC article.
-
Presaturation Power Adjusted Pulsed CEST: A Method to Increase Independence of Target CEST Signals.Contrast Media Mol Imaging. 2018 May 8;2018:3141789. doi: 10.1155/2018/3141789. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 29853805 Free PMC article.